Pacific Biosciences's total assets for Q1 2026 were $782.37M, a decrease of -0.22% from the previous quarter. PACB total liabilities were $780.00M for the fiscal quarter, a 0.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.